These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32438990)

  • 1. Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.
    Guedeney P; Barthélémy O; Zeitouni M; Hauguel-Moreau M; Hage G; Kerneis M; Lattuca B; Overtchouk P; Rouanet S; Fuernau G; de Waha-Thiele S; Zeymer U; Sandri M; Akin I; Desch S; Thiele H; Montalescot G
    JACC Cardiovasc Interv; 2020 May; 13(10):1198-1206. PubMed ID: 32438990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.
    Rubini Gimenez M; Zeymer U; Desch S; de Waha-Thiele S; Ouarrak T; Poess J; Meyer-Saraei R; Schneider S; Fuernau G; Stepinska J; Huber K; Windecker S; Montalescot G; Savonitto S; Jeger RV; Thiele H
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008537. PubMed ID: 32151161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    Thiele H; Akin I; Sandri M; Fuernau G; de Waha S; Meyer-Saraei R; Nordbeck P; Geisler T; Landmesser U; Skurk C; Fach A; Lapp H; Piek JJ; Noc M; Goslar T; Felix SB; Maier LS; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Barthelemy O; Huber K; Windecker S; Savonitto S; Torremante P; Vrints C; Schneider S; Desch S; Zeymer U;
    N Engl J Med; 2017 Dec; 377(25):2419-2432. PubMed ID: 29083953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culprit Vessel Only Versus Multivessel Percutaneous Coronary Intervention in Acute Myocardial Infarction with Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Khalid MF; Khan AA; Khattak F; Ayub MT; Bagai J; Mukherjee D; Helton T; Cohen MG; Banerjee S; Paul TK
    Cardiovasc Revasc Med; 2019 Nov; 20(11):956-964. PubMed ID: 30638891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Kundu A; Sardar P; Kakouros N; Malhotra R; Kolte D; Feldman DN; Abbott JD; Fisher DZ
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):70-81. PubMed ID: 30593731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.
    Choi KH; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Ahn CM; Yu CW; Park IH; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Kang TS; Gwon HC
    J Am Heart Assoc; 2023 May; 12(10):e029792. PubMed ID: 37158104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
    Barthélémy O; Rouanet S; Brugier D; Vignolles N; Bertin B; Zeitouni M; Guedeney P; Hauguel-Moreau M; Hage G; Overtchouk P; Akin I; Desch S; Vicaut E; Zeymer U; Thiele H; Montalescot G
    J Am Coll Cardiol; 2021 Jan; 77(2):144-155. PubMed ID: 33446307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest.
    Zeymer U; Alushi B; Noc M; Mamas MA; Montalescot G; Fuernau G; Huber K; Poess J; de Waha-Thiele S; Schneider S; Ouarrak T; Desch S; Lauten A; Thiele H
    J Am Coll Cardiol; 2023 Mar; 81(12):1165-1176. PubMed ID: 36948733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    Thiele H; Akin I; Sandri M; de Waha-Thiele S; Meyer-Saraei R; Fuernau G; Eitel I; Nordbeck P; Geisler T; Landmesser U; Skurk C; Fach A; Jobs A; Lapp H; Piek JJ; Noc M; Goslar T; Felix SB; Maier LS; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Barthelemy O; Huber K; Windecker S; Hunziker L; Savonitto S; Torremante P; Vrints C; Schneider S; Zeymer U; Desch S;
    N Engl J Med; 2018 Nov; 379(18):1699-1710. PubMed ID: 30145971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK Trial.
    Sag CM; Zeymer U; Ouarrak T; Schneider S; Montalescot G; Huber K; Fuernau G; Freund A; Feistritzer HJ; Desch S; Thiele H; Maier LS
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009562. PubMed ID: 32883104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock.
    Lemor A; Basir MB; Patel K; Kolski B; Kaki A; Kapur NK; Riley R; Finley J; Goldsweig A; Aronow HD; Belford PM; Tehrani B; Truesdell AG; Lasorda D; Bharadwaj A; Hanson I; LaLonde T; Gorgis S; O'Neill W;
    JACC Cardiovasc Interv; 2020 May; 13(10):1171-1178. PubMed ID: 32360256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.
    Braik N; Guedeney P; Behnes M; Desch S; Barthélémy O; Sandri M; de Waha-Thiele S; Fuernau G; Rouanet S; Hauguel-Moreau M; Zeitouni M; Overtchouk P; Ouarrak T; Schneider S; Zeymer U; Thiele H; Montalescot G; Akin I
    Am Heart J; 2021 Feb; 232():185-193. PubMed ID: 33253678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
    Fuernau G; Fengler K; Desch S; Eitel I; Neumann FJ; Olbrich HG; de Waha A; de Waha S; Richardt G; Hennersdorf M; Empen K; Hambrecht R; Jung C; Böhm M; Pöss J; Strasser RH; Schneider S; Ouarrak T; Schuler G; Werdan K; Zeymer U; Thiele H
    Clin Res Cardiol; 2016 Dec; 105(12):1030-1041. PubMed ID: 27378612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of baseline and residual SYNTAX scores in cardiogenic shock.
    Javanainen T; Sans-Roselló J; Harjola VP; Nieminen MS; Lassus J; Sionis A; Varpula M; Jurkko R
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):1-8. PubMed ID: 30208254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.
    Zeymer U; Werdan K; Schuler G; Zahn R; Neumann FJ; Fürnau G; de Waha S; Schneider S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):601-609. PubMed ID: 27655918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction.
    Vis MM; Beijk MA; Grundeken MJ; Baan J; Koch KT; Wykrzykowska JJ; Arkenbout EK; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):317-24. PubMed ID: 23597607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.